Autoimmune inner ear disease secondary to Hashimoto’s thyroiditis: a case report

Fayyaz, Beenish; Upreti, Sunita

doi:10.1080/20009666.2018.1503917

Cited by 9 publications

(9 citation statements)

References 16 publications

(9 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, a later study could not replicate this result ( Papi et al., 2010 ). Therefore, it is likely that thyroid autoimmunity is a risk factor for developing other disorders of the inner ear, such as autoimmune hearing loss or Meniere’s disease ( Fayyaz and Upreti, 2018 ; Sari et al., 2015 ).…”

Section: Otoconial Mineralization and Bppvmentioning

confidence: 99%

Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors

Guerra¹,

Devesa²

2020

Journal of Otology

View full text Add to dashboard Cite

The genesis of the Benign Paroxysmal Positional Vertigo (BPPV) seems to be related to some metabolic factors. These factors, such as vitamin D, glucocorticoids, and even thyroid and growth hormones, can affect bone metabolism and the mineralization of otoconia. It also seems to link to factors related to aging or nutritional habits. Besides, since the incidence of BPPV is quantitatively higher in women than in men, female sex steroids could be associated with this process. It could be useful to understand how these factors act in otoconial mineralization if we want to develop treatments aimed at preventing or delaying BPPV recurrences. In this review, we will analyze the role of these metabolic and hormonal factors in otoconial mineralization and in the treatment of BPPV.

show abstract

Section: Otoconial Mineralization and Bppvmentioning

confidence: 99%

Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors

Guerra¹,

Devesa²

2020

Journal of Otology

View full text Add to dashboard Cite

show abstract

“…Yuan et.al, 2019 reported highest prevalence of vitiligo in subclinical hypothyroidism, among 6 types of thyroid disorders [195]. Subclinical hypothyroidism is most often caused by autoimmune (Hashimoto) thyroiditis [196], who are at higher risk of developing audiological abnormalities as compared to the healthy individuals [197]. Hypothyroidism may also cause alveolar hypoventilation, decreased lung volumes, upper airway obstruction, depression in respiratory stimulus, and respiratory failure [198].…”

Section: Thyroid Disordersmentioning

confidence: 99%

Clinical Pharmacists in Chronic Care [Part 2]

Mohiuddin¹

2020

ABEB

View full text Add to dashboard Cite

This work is licensed under Creative Commons Attribution 4.0 License ABEB.MS.ID.000566.Background Clinical pharmacology is a professional discipline that combines basic pharmacology and clinical medicine. A clinical pharmacist offers invaluable support in the development of a final prescription with better patient management and enhanced safety [1]. Its development began in the early 1950s, primarily as a result of the efforts of Harry Gold. Pharmacist rounding with inpatient hospital services has been traced to the University of Kentucky in 1957 [1,2]. Drug therapy was becoming much more complex. Graham Calder pioneered a new role for pharmacists on hospital wards in Aberdeen [3]. The role of clinical pharmacists underwent significant changes from the 1960s through 1990s as their participation in direct patient care enhanced. In the early 1970s, federal funding assisted with greatly expanding clinical pharmacy faculty in Colleges of Pharmacy [4]. Pharmacy education debated where clinical pharmacy fit within pharmacy training.The AACP spearheaded an effort to examine this issue. Till then, two full generations of pharmacists have been educated and trained after the general adoption of the aims of clinical pharmacy

show abstract

Section: Thyroid Disordersmentioning

confidence: 99%

Clinical Pharmacists in Chronic Care

Mohiuddin¹

2019

GJMR

View full text Add to dashboard Cite

Pharmacy practice has changed significantly lately. The professionals have the chance to contribute straightforwardly to patient consideration so as to lessen morbimortality identified with medication use, promoting wellbeing and preventing diseases. Healthcare organizations worldwide are under substantial pressure from increasing patient demand. Unfortunately, a cure is not always possible particularly in this era of chronic complications, and the role of physicians has become limited to controlling and palliating symptoms.The increasing population of patients with longterm conditions are associated with high levels of morbidity, healthcare costs and GP workloads. Clinical pharmacy took over an aspect of medical care that had been partially abandoned by physicians. Overburdened by patient loads and the explosion of new drugs, physicians turned to pharmacists more and more for drug information, especially within institutional settings. Once relegated to counting and pouring, pharmacists headed institutional reviews of drug utilization and served as consultants to all types of health-care facilities. In addition, when clinical pharmacists are active members of the care team, they enhance proficiency by: Providing critical input on medicine use and dosing. Working with patients to solve problems with their medications and improve compliance.

show abstract

Autoimmune inner ear disease secondary to Hashimoto’s thyroiditis: a case report

Cited by 9 publications

References 16 publications

Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors

Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors

Clinical Pharmacists in Chronic Care [Part 2]

Clinical Pharmacists in Chronic Care

Contact Info

Product

Resources

About